Designing a Science-based Strategy to Prepare for the Next Pandemic
DOI:
https://doi.org/10.47611/jsrhs.v10i4.2051Keywords:
SARS-CoV-2, COVID-19, pandemic preparation, anti-viral drug discovery, healthcare infrastructure,Abstract
The emergence of SARS-CoV-2 led to a severe pandemic across the world. However, the globe did not response to the pandemic properly and preparedly, causing the impact of the pandemic to be more adverse than it should be. Many lessons can be learned from the experience of tackling the current pandemic and used to help prepare for the next pandemic, which is inevitable. In finding out the most suitable preparation strategy, research was conducted on the epidemiology of the coronavirus, current therapeutic options for treatment of COVID-19, and current anti-epidemic strategies and policies. It was determined that efficient tactics to prepare for and combat next virus outbreak include developing anti-viral drugs, improving healthcare infrastructure, and educating the general public. If these measures can be implemented, preparedness for the next pandemic will be significantly improved, leading to significantly reduced severity of the pandemic.
Downloads
References or Bibliography
CDC. Symptoms of covid-19. Retrieved August 20 from https://www.cdc.gov/coronavirus/2019-ncov/symptoms-testing/symptoms.html
CDC. (2020). Case Investigation and Contact Tracing : Part of a Multipronged Approach to Fight the COVID-19 Pandemic. Retrieved August 20 from https://www.cdc.gov/coronavirus/2019-ncov/php/principles-contact-tracing.html
Dolgin, E. (2021). The race for antiviral drugs to beat COVID — and the next pandemic. Nature, 592, 340-343. https://doi.org/https://doi.org/10.1038/d41586-021-00958-4
Frieden, T. R., Buissonnière, M., & McClelland, A. (2021). The world must prepare now for the next pandemic. BMJ Glob Health, 6(3). https://doi.org/10.1136/bmjgh-2021-005184
Gao, Z., Xu, Y., Sun, C., Wang, X., Guo, Y., Qiu, S., & Ma, K. (2021). A systematic review of asymptomatic infections with COVID-19. J Microbiol Immunol Infect, 54(1), 12-16. https://doi.org/10.1016/j.jmii.2020.05.001
Hotez, P. (2021). COVID vaccines: time to confront anti-vax aggression. In (Vol. 592, pp. 661). Nature.
Jin, Y., Yang, H., Ji, W., Wu, W., Chen, S., Zhang, W., & Duan, G. (2020). Virology, Epidemiology, Pathogenesis, and Control of COVID-19. Viruses, 12(4). https://doi.org/10.3390/v12040372
Kandola, A. (2020). Anti-vaxxer: Definition, beliefs, risks, and more. Medilexicon International. Retrieved August 20 from https://www.medicalnewstoday.com/articles/anti-vaxxer
Kathleen, J. (2021). How to Debunk Misinformation about COVID, Vaccines and Masks. In We each have more power to be a science communicator than we realize (Vol. 324, pp. 44-51). Scientific American.
Maani, N., & Galea, S. (2020). COVID-19 and Underinvestment in the Public Health Infrastructure of the United States. The Milbank Quarterly, 98. https://doi.org/10.1111/1468-0009.12463
Sayers, A., McMahon, N., & Alcantara, C. (2021). The COVID-19 crisis is about physical infrastructure too. Retrieved August 20 from https://www.ssc.uwo.ca/news/2021/the_covid19_crisis_is_about_physical_infrastructure_too.html
Soy, A. (2020). Coronavirus in AFRICA: Five reasons why covid-19 has been less deadly than elsewhere. BBC. Retrieved August 20 from https://www.bbc.com/news/world-africa-54418613
Triggle, C. R., Bansal, D., Ding, H., Islam, M. M., Farag, E. A. B. A., Hadi, H. A., & Sultan, A. A. (2021). A Comprehensive Review of Viral Characteristics, Transmission, Pathophysiology, Immune Response, and Management of SARS-CoV-2 and COVID-19 as a Basis for Controlling the Pandemic. Front Immunol, 12, 631139. https://doi.org/10.3389/fimmu.2021.631139
Worldometer. Coronavirus cases. Retrieved August 20 from https://www.worldometers.info/coronavirus/
Yüce, M., Filiztekin, E., & Özkaya, K. G. (2021). COVID-19 diagnosis -A review of current methods. Biosens Bioelectron, 172, 112752. https://doi.org/10.1016/j.bios.2020.112752
Published
How to Cite
Issue
Section
Copyright (c) 2021 Letian Xue; Reto Asmis, Mark Crowder
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Copyright holder(s) granted JSR a perpetual, non-exclusive license to distriute & display this article.
